104 related articles for article (PubMed ID: 6260509)
1. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells.
Black PL; Vitetta ES; Forman J; Kang CY; May RD; Uhr JW
Eur J Immunol; 1981 Jan; 11(1):48-55. PubMed ID: 6260509
[TBL] [Abstract][Full Text] [Related]
2. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
Harris DT; Hale AH; Lefrancois L
J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
[TBL] [Abstract][Full Text] [Related]
3. Vesicular stomatitis antigens recognized by cytotoxic cells: analysis with defective interfering particles and reconstituted membrane vesicles.
Ciavarra RP; Kang CY; Forman J
J Immunol; 1980 Jul; 125(1):336-43. PubMed ID: 6247397
[No Abstract] [Full Text] [Related]
4. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
Zinkernagel RM; Althage A; Holland J
J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
Browning MJ; Huang AS; Reiss CS
J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
[TBL] [Abstract][Full Text] [Related]
6. Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk.
Rosenthal KL; Zinkernagel RM
J Immunol; 1981 Feb; 126(2):446-51. PubMed ID: 6256440
[TBL] [Abstract][Full Text] [Related]
7. Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus.
Rosenthal KL; Oldstone MB; Hengartner H; Zinkernagel RM
J Immunol; 1983 Jul; 131(1):475-8. PubMed ID: 6190924
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein.
Hale AH; Ruebush MJ; Lefrançois L
Eur J Immunol; 1981 May; 11(5):434-6. PubMed ID: 6266837
[TBL] [Abstract][Full Text] [Related]
9. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
Bachmann MF; Hengartner H; Zinkernagel RM
Eur J Immunol; 1995 Dec; 25(12):3445-51. PubMed ID: 8566036
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein.
Lefrancois L; Lyles DS
J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583
[TBL] [Abstract][Full Text] [Related]
11. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
[TBL] [Abstract][Full Text] [Related]
12. The nature of hemopoietic histocompatibility determinants. Differential sensitivity of Hh-1b and H-2b determinants to tunicamycin.
Milisauskas VK; Nakamura I
J Immunol; 1988 Aug; 141(4):1246-51. PubMed ID: 2456347
[TBL] [Abstract][Full Text] [Related]
13. The role of vesicular stomatitis virus major glycoprotein in determining the specificity of virus-specific and H-2-restricted cytolytic T cells.
Sethi KK; Brandis H
Eur J Immunol; 1980 Apr; 10(4):268-72. PubMed ID: 6249612
[No Abstract] [Full Text] [Related]
14. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glycosylation prevents H-2K and D antigen expression on SV40 virus-transformed cells.
Swaminathan S; Gooding LR
Eur J Immunol; 1983 Apr; 13(4):335-40. PubMed ID: 6303796
[TBL] [Abstract][Full Text] [Related]
16. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
Sheil JM; Bevan MJ; Lefrancois L
J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
[TBL] [Abstract][Full Text] [Related]
17. Expression of H-2 and viral antigens and resistance to the antitumor lysis of tunicamycin-treated MBL-2 lymphoma cells.
Colombo MP; Pierotti MA; Ballinari D; Parmiani G
Immunobiology; 1983 Aug; 165(2):186-99. PubMed ID: 6605298
[TBL] [Abstract][Full Text] [Related]
18. Elicitation and specificity of anti-vesicular stomatitis virus-specific cytotoxic T lymphocytes.
Ruebush MJ; Hale AH; Lefrancois L; Harris DT; Burgess DE
J Immunol; 1981 May; 126(5):2053-9. PubMed ID: 6260862
[No Abstract] [Full Text] [Related]
19. Limitation of VSV infection by the host's response to VSV-associated cellular antigens.
Hecht TT; Paul WE
J Immunol; 1982 Oct; 129(4):1736-41. PubMed ID: 6180021
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
